Scrying Biotech
Long only, biotech, micro-cap, small-cap

With Or Without You Cyclacel Is Going To Rise

I've watched this happen too many times now. A stock stagnates in the winter of investor apathy only to shoot up suddenly like the tendrils of a tulip in spring. By then of course, it's too late. Your inattention has cost you a fortune. But before I explain why this is the case with Cyclacel (CYCC) Pharmaceuticals allow me to giv...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason, less the minimum required payment - the cost of a one day pass.